Cargando…

Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Loucera, Carlos, Esteban-Medina, Marina, Rian, Kinza, Falco, Matías M., Dopazo, Joaquín, Peña-Chilet, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729141/
https://www.ncbi.nlm.nih.gov/pubmed/33311438
http://dx.doi.org/10.1038/s41392-020-00417-y
_version_ 1783621394021482496
author Loucera, Carlos
Esteban-Medina, Marina
Rian, Kinza
Falco, Matías M.
Dopazo, Joaquín
Peña-Chilet, María
author_facet Loucera, Carlos
Esteban-Medina, Marina
Rian, Kinza
Falco, Matías M.
Dopazo, Joaquín
Peña-Chilet, María
author_sort Loucera, Carlos
collection PubMed
description
format Online
Article
Text
id pubmed-7729141
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-77291412020-12-11 Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection Loucera, Carlos Esteban-Medina, Marina Rian, Kinza Falco, Matías M. Dopazo, Joaquín Peña-Chilet, María Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-12-11 /pmc/articles/PMC7729141/ /pubmed/33311438 http://dx.doi.org/10.1038/s41392-020-00417-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Loucera, Carlos
Esteban-Medina, Marina
Rian, Kinza
Falco, Matías M.
Dopazo, Joaquín
Peña-Chilet, María
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title_full Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title_fullStr Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title_full_unstemmed Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title_short Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
title_sort drug repurposing for covid-19 using machine learning and mechanistic models of signal transduction circuits related to sars-cov-2 infection
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729141/
https://www.ncbi.nlm.nih.gov/pubmed/33311438
http://dx.doi.org/10.1038/s41392-020-00417-y
work_keys_str_mv AT louceracarlos drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection
AT estebanmedinamarina drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection
AT riankinza drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection
AT falcomatiasm drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection
AT dopazojoaquin drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection
AT penachiletmaria drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection